Molecular Diagnostic Laboratory Services
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Department of State, Bureau of Global Health Security and Diplomacy (GHSD), is issuing a Request for Information (RFI) for Molecular Diagnostic Laboratory Services. This RFI seeks input from qualified manufacturers for an all-inclusive molecular diagnostic laboratory service to support the America First Global Health Security (AFGHS) strategy across Sub-Saharan African and potentially other countries. Responses will inform the final Performance Work Statement (PWS) and are due by June 17, 2026, 5:00 PM EST.
Scope of Work
The envisioned service involves continuous, fully managed molecular diagnostic goods and services. This includes testing for HIV viral load (VL) and early infant diagnosis (EID), tuberculosis (TB) diagnosis (including drug resistance), and Global Health Security (GHS) pathogens such as Ebola and Marburg. Additional tests like HPV, HBV, and HCV may also be incorporated. The model is an all-inclusive, per-test arrangement, where the Contractor is responsible for the entire process, from instrument placement and reagent delivery to maintenance, training, cold chain logistics, and data connectivity.
Key Requirements & Eligibility
Respondents must be U.S. manufacturers (incorporated in the U.S. or U.S.-incorporated subsidiaries of foreign companies) with majority U.S.-based R&D and manufacturing. Platforms must be closed-system, SRA-approved, and support automated data transmission. Mandatory operational presence in Sub-Saharan Africa, cold chain/last-mile distribution capability, and an ISO 15189-aligned Quality Management System are required. Pricing will be an all-inclusive per-test model with Global Goods and Country-Specific Services components, tiered by volume. Data security and privacy regulations must be strictly adhered to, with data stored in approved U.S. environments.
Response Details
Responses are optional and requested from qualified and eligible manufacturers of molecular diagnostic platforms. Questions ask about specific contracted countries (address individually) and current operational data/performance metrics (provide actual data). Responses should be succinct (800-character count/question). Submissions are to be made via the provided link: https://forms.cloud.microsoft/g/smW7MpdKHN. Email responses will not be accepted.
Contract & Timeline
- Opportunity Type: Sources Sought (Request for Information)
- Published Date: April 14, 2026
- Response Due: June 17, 2026, 5:00 PM EST
- Place of Performance: Designated laboratory sites within contracted countries in Sub-Saharan Africa, Southeast Asia, and Latin America.
Additional Notes
This RFI is for planning purposes only and does not constitute a solicitation or obligate the Government to issue one or make an award. No reimbursement will be made for response costs. Not responding or providing limited responses will not impact future competition outcomes.